• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Werewolf Therapeutics, Inc. - Common Stock (NQ:HOWL)

0.9708 -0.0180 (-1.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,217,838
Open 0.9900
Bid (Size) 0.9481 (1,000)
Ask (Size) 0.9497 (1,100)
Prev. Close 0.9888
Today's Range 0.9144 - 0.9981
52wk Range 0.2700 - 2.380
Shares Outstanding 27,567,728
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, CBZ are Obtaining Fair Deals for their Shareholders
August 24, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ)
August 24, 2026
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+50.6%
+50.6%
1 Month
+116.1%
+116.1%
3 Month
+112.9%
+112.9%
6 Month
+53.6%
+53.6%
1 Year
-27.0%
-27.0%

More News

Read More
News headline image
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
August 23, 2026
From Halper Sadeh LLC
Via Business Wire
Friday's session: top gainers and losers ↗
August 21, 2026
Via Chartmill
Werewolf Therapeutics (NASDAQ:HOWL) Meets Q1 Estimates, Clears Debt, and Advances Strategic Review ↗
May 07, 2026
Via Chartmill
Friday's session: most active stocks ↗
August 21, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 21, 2026
Via Benzinga
The trading volume of these stocks is deviating from the norm in today's session. ↗
August 21, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
August 21, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
August 21, 2026
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
August 21, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 21, 2026
Via Benzinga
News headline image
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
August 21, 2026
From Ambros Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 20, 2026
Via Benzinga
These stocks are moving in today's after hours session ↗
August 20, 2026
Via Chartmill
News headline image
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
July 31, 2026
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
These stocks are moving in today's after hours session ↗
May 15, 2026
Via Chartmill
News headline image
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
May 07, 2026
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
March 27, 2026
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
February 24, 2026
From Werewolf Therapeutics, Inc.
Via GlobeNewswire
News headline image
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives ↗
February 13, 2026
Via Stocktwits
Topics Workforce
News headline image
Top movers in Thursday's session ↗
December 18, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
December 18, 2025
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
December 18, 2025
Via Chartmill
News headline image
Werewolf Therapeutics Announces Pipeline and Business Updates
December 18, 2025
From Werewolf Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Werewolf Therapeutics, Inc. - Common Stock publicly traded?
Yes, Werewolf Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Werewolf Therapeutics, Inc. - Common Stock trade on?
Werewolf Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Werewolf Therapeutics, Inc. - Common Stock?
The ticker symbol for Werewolf Therapeutics, Inc. - Common Stock is HOWL on the Nasdaq Stock Market
What is the current price of Werewolf Therapeutics, Inc. - Common Stock?
The current price of Werewolf Therapeutics, Inc. - Common Stock is 0.9708
When was Werewolf Therapeutics, Inc. - Common Stock last traded?
The last trade of Werewolf Therapeutics, Inc. - Common Stock was at 08/27/26 04:00 PM ET
What is the market capitalization of Werewolf Therapeutics, Inc. - Common Stock?
The market capitalization of Werewolf Therapeutics, Inc. - Common Stock is 26.76M
How many shares of Werewolf Therapeutics, Inc. - Common Stock are outstanding?
Werewolf Therapeutics, Inc. - Common Stock has 27M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap